e-learning
resources
ERJ
2017
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pseudomonas aeruginosa adaptation and diversification in the non-cystic fibrosis bronchiectasis lung
Yasmin Hilliam, Matthew P. Moore, Iain L. Lamont, Diana Bilton, Charles S. Haworth, Juliet Foweraker, Martin J. Walshaw, David Williams, Joanne L. Fothergill, Anthony De Soyza, Craig Winstanley
Source:
Eur Respir J , 49 (4) 1602108; DOI: 10.1183/13993003.02108-2016
Journal Issue:
April
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Yasmin Hilliam, Matthew P. Moore, Iain L. Lamont, Diana Bilton, Charles S. Haworth, Juliet Foweraker, Martin J. Walshaw, David Williams, Joanne L. Fothergill, Anthony De Soyza, Craig Winstanley. Pseudomonas aeruginosa adaptation and diversification in the non-cystic fibrosis bronchiectasis lung. Eur Respir J , 49 (4) 1602108; DOI: 10.1183/13993003.02108-2016
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
Cystic fibrosis and intestinal organoids
Related content which might interest you:
Epidemiology and natural history of
Pseudomonas aeruginosa
airway infections in non-cystic fibrosis bronchiectasis
Source: ERJ Open Res, 4 (2) 00162-2017; 10.1183/23120541.00162-2017
Year: 2018
Mucoid Pseudomonas aeruginosa alter sputum viscoelastic properties in patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection
Year: 2019
Factors associated with infection by Pseudomonas aeruginosa in adult cystic fibrosis
Source: Eur Respir J 2005; 26: 651-656
Year: 2005
Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa
Source: Eur Respir J 2003; 22: 503-506
Year: 2003
Epidemiological-molecular study of colonization by pseudomonas aeruginosa in cystic fibrosis patients
Source: Eur Respir J 2002; 20: Suppl. 38, 379s
Year: 2002
Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis
Source: Eur Respir J 2007; 30: 286-292
Year: 2007
Molecular epidemiological analysis suggests cross-infection with Pseudomonas aeruginosa is rare in non-cystic fibrosis bronchiectasis
Source: Eur Respir J 2014; 43: 900-903
Year: 2014
Pseudomonas aeruginosa infections
Source: Respipedia Article
Year: 2018
Chronic but not intermittent infection with
Pseudomonas aeruginosa
is associated with global changes of the lung microbiome in cystic fibrosis
Source: Eur Respir J, 50 (4) 1701086; 10.1183/13993003.01086-2017
Year: 2017
Evaluating the Leeds criteria for Pseudomonas aeruginosa infection in a cystic fibrosis centre
Source: Eur Respir J 2006; 27: 937-943
Year: 2006
The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis
Source: Eur Respir J 2006; 28: 974-979
Year: 2006
Sputum versus bronchoscopy for diagnosis of Pseudomonas aeruginosa biofilms in cystic fibrosis
Source: Eur Respir J 2004; 24 : 631-637
Year: 2004
Eradication of Pseudomonas aeruginosa in cystic fibrosis
Source: Eur Respir J 2006; 27: 438-439
Year: 2006
Temperate bacteriophages of
pseudomonas aeruginosa
as markers of bacterial adaptation in CF and non-CF bronchiectasis
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014
Eradication of Pseudomonas aeruginosa in cystic fibrosis patients
Source: Eur Respir J 2006; 27: 653
Year: 2006
Does sputum induction improve
Pseudomonas aeruginosa
detection in cystic fibrosis?
Source: Eur Respir J 2003; 22: Suppl. 45, 231s
Year: 2003
Bacterial cyanogenesis occurs in the cystic fibrosis lung
Source: Eur Respir J 2008; 32: 329-333
Year: 2008
Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients
Source: Eur Respir J 2008; 31: 822-829
Year: 2008
Epidemiology of Pseudomonas aeruginosa in a cystic fibrosis rehabilitation centre
Source: Eur Respir J 2005; 25: 474-481
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept